Lifecore Biomedical, Inc. De (LFCR) Operating Expenses (2010 - 2025)

Lifecore Biomedical's Operating Expenses history runs 16 years deep, the most recent figure standing at $8.6 million for Q2 2025.

• In Q2 2025, Operating Expenses fell 43.37% year-over-year to $8.6 million; the TTM figure through May 2025 stood at $50.5 million (changed 0.41% YoY), while the FY2025 annual figure was $50.6 million, changed 0.27% from the prior year.
• Operating Expenses was $8.6 million for Q2 2025 at Lifecore Biomedical, down from $11.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $21.3 million in Q1 2022 to a low of $3.1 million in Q2 2021.
• Historically, Operating Expenses has averaged $12.0 million across 5 years, with a median of $11.7 million in 2023.
• The sharpest annual moves came in 2021 and 2022: Operating Expenses sank 69.03% in 2021, then jumped 289.24% in 2022.
• A 5-year view of Operating Expenses shows it stood at $7.8 million in 2021, then soared by 42.01% to $11.0 million in 2022, then increased by 3.71% to $11.4 million in 2023, then rose by 14.01% to $13.0 million in 2024, then sank by 34.34% to $8.6 million in 2025.
• The last three Operating Expenses figures came in at $8.6 million (Q2 2025), $11.9 million (Q1 2025), and $13.0 million (Q4 2024), per Business Quant data.